Blueprint Medicines Corporation
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
15.98 | 57.09 | -72.01% | 2.05 | +677.76% |
| P/S |
|
21.57 | 33.5 | -35.6% |
|
|
| P/BV |
|
41.19 | 4.61 | 792.62% |
|
|
| P/FCF |
|
-6.6 | 39.66 | -116.65% |
|
|
| Ev/Ebitda |
|
-12.82 | -19.46 | -34.13% |
|
|
| Ev/S |
|
24.39 | 22.56 | 8.11% |
|
|
| Ev/FCF |
|
-13.43 | 45.47 | -129.53% |
|
|
| E/P |
|
-0.1696 | 0.0172 | -1083.34% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-190.32 | -14.42 | 1219.75% | -189.83 | +0.2568% |
| ROE |
|
-388.17 | 9.01 | -4408.01% |
|
|
| ROA |
|
-48.32 | 0.0151 | -319146.18% |
|
|
| ROIC |
|
-52.47 | 7.63 | -787.29% |
|
|
| ROS |
|
-203.3 | -26.5 | 667.03% |
|
|
| ROCE |
|
-372.32 | 13.75 | -2807.2% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.6109 | -3.73 | -83.61% | -0.827 | -26.13% |
| Nеt Debt/Ebitda |
|
-1.48 | -3.19 | -53.63% |
|
|
| Debt/Ratio |
|
0.2763 | 0.1777 | 55.49% |
|
|
| Debt/Equity |
|
8.71 | 1.57 | 454.04% |
|
|
| Debt/Net Income |
|
-0.5719 | 0.8429 | -167.85% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
275.01 | 73.67 | 273.3% | ||
| Growth impulse Ebitda in 5 years |
|
30.18 | 15.28 | 97.51% | ||
| Growth impulse Net Income in 5 years |
|
54.19 | -33.08 | -263.81% | ||
| Growth impulse FCF in 5 years |
|
55.11 | -6.99 | -888.41% | ||
| Growth impulse EPS in 5 years |
|
21.86 | -59.11 | -136.98% |
IP Score
3.72/10
